Mahmood Hussain

mahmood-hussan

Chylos, Inc.

2015-2016

Affiliations

State University of New York

Technologies

Therapeutic

Indication

Cardiovascular Disease

Metabolic Disease

Obesity

We have discovered a microRNA, miR-30c, which lowers plasma cholesterol and atherosclerosis in mice. We would like to commercialize it as a drug to treat hyperlipidemia and atherosclerosis.

Newsletter Signup

Corporate Supporters

Community Service Providers